Ieq Capital, LLC Amgen Inc Transaction History

Ieq Capital, LLC

$8.04 Billion
Q3 2024

A detailed history of Ieq Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Ieq Capital, LLC holds 53,342 shares of AMGN stock, worth $14.1 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

53,342

Previous 51,921 2.74%

Holding current value

$14.1 Million

Previous $16.2 Million 5.95%

% of portfolio

0.21%

Previous 0.22%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$309.38 - $337.38 $439,628 - $479,416	1,421 Added 2.74%	53,342 $17.2 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $987,151 - $1.2 Million	3,757 Added 7.8%	51,921 $16.2 Million
Q1 2024 May 08, 2024	BUY	$268.87 - $324.56 $497,140 - $600,111	1,849 Added 3.99%	48,164 $13.7 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $609,333 - $687,400	2,383 Added 5.42%	46,315 $13.3 Million
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $915,050 - $1.14 Million	4,185 Added 10.53%	43,932 $11.8 Million
Q2 2023 Aug 07, 2023	SELL	$214.27 - $253.37 $232,697 - $275,159	-1,086 Reduced 2.66%	39,747 $8.82 Million
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $1.02 Million - $1.24 Million	-4,513 Reduced 9.95%	40,833 $9.87 Million
Q4 2022 Feb 03, 2023	BUY	$229.03 - $291.01 $656,399 - $834,034	2,866 Added 6.75%	45,346 $11.9 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $1.68 Million - $1.9 Million	7,498 Added 21.43%	42,480 $9.58 Million
Q2 2022 Jul 27, 2022	BUY	$230.71 - $256.74 $1.06 Million - $1.18 Million	4,596 Added 15.13%	34,982 $8.51 Million
Q1 2022 Apr 26, 2022	BUY	$219.27 - $242.57 $1.15 Million - $1.27 Million	5,228 Added 20.78%	30,386 $7.35 Million
Q4 2021 Jan 31, 2022	BUY	$198.88 - $227.6 $582,718 - $666,868	2,930 Added 13.18%	25,158 $5.66 Million
Q3 2021 Nov 09, 2021	SELL	$212.27 - $248.7 $460,625 - $539,679	-2,170 Reduced 8.89%	22,228 $4.73 Million
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $801,880 - $889,627	3,433 Added 16.37%	24,398 $5.95 Million
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $1.73 Million - $2.01 Million	7,782 Added 59.03%	20,965 $5.22 Million
Q4 2020 Feb 03, 2021	SELL	$216.38 - $257.67 $1.74 Million - $2.07 Million	-8,052 Reduced 37.92%	13,183 $3.03 Million
Q3 2020 Nov 03, 2020	BUY	$234.65 - $260.95 $262,104 - $291,481	1,117 Added 5.55%	21,235 $5.4 Million
Q2 2020 Jul 31, 2020	BUY	$197.81 - $242.74 $1.7 Million - $2.08 Million	8,580 Added 74.36%	20,118 $4.75 Million
Q1 2020 May 07, 2020	BUY	$182.24 - $241.7 $337,872 - $448,111	1,854 Added 19.14%	11,538 $2.34 Million
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $311,061 - $399,820	-1,644 Reduced 14.51%	9,684 $2.34 Million
Q4 2019 Feb 04, 2020	BUY	$189.21 - $243.2 $2.14 Million - $2.75 Million	11,328 New	11,328 $498,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ieq Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ieq Capital, LLC with notifications on news.

Account